Growth hormone (GH) is secreted by the pituitary in pulses, primarily during deep sleep. What is the relationship between IGF-1 and growth hormone? However, IGF-1 within the functional medicine optimal range of 120 to 200 ng/mL has less clear cancer risk while providing well-established benefits for muscle mass, bone density, cognitive function, and metabolic health. Functional medicine targets a middle range corresponding to the levels seen in younger, optimally healthy adults, rather than accepting age-related decline as inevitable.
Training capacity increases because recovery is enhanced from multiple angles. Clients who commit to the MK-677 plus enclomiphene stack for 12 weeks with consistent training and nutrition typically report results that surprised them. The appetite increase from MK-677 is the one side effect that the stack does not inherently address. Enclomiphene alters estrogenic signaling in the brain, while MK-677’s GH elevation can cause fatigue in some individuals. The side effects of this stack are essentially the side effects of each compound individually, with one important interaction to monitor. The net result is elevated testosterone from enclomiphene combined with elevated IGF-1 from MK-677, giving you the best of both hormonal worlds without either compound undermining the other. Ipamorelin is administered subcutaneously — small insulin needles into the belly fat or outer thigh.
Resistance training is a potent stimulator of both local (muscle-derived) and systemic IGF-1. For IGF-1 optimization, I recommend a minimum of 1.6g/kg of body weight in high-quality protein daily, spread across 3-4 meals with at least 30-40g per meal to maximize leucine threshold activation. Leucine is particularly important because it activates mTOR signaling, which works synergistically with IGF-1 to drive muscle protein synthesis. Multiple studies have shown that vegetarians and vegans tend to have 10-15% lower IGF-1 levels than omnivores, likely due to differences in essential amino acid profiles and overall protein quality. IGF-1 production requires adequate amino acid availability, particularly from animal protein sources. I’ve had clients whose IGF-1 levels jumped 30-40% just from fixing their sleep — no supplements, no peptides, no drugs.
The libido improvements some users report are likely a combination of improved sleep, better IGF-1, and improved body composition — not a direct hormonal effect. Testosterone production is heavily dependent on sleep quality — particularly deep sleep. As ipamorelin-driven fat loss reduces visceral fat, testosterone-to-estrogen ratio can improve passively. If you're looking for a testosterone-boosting peptide, this isn't it — you'd want to look at something like Kisspeptin or PT-141 for those effects. It doesn't stimulate LH, FSH, or testicular testosterone production. Significant body recomposition, noticeably improved skin quality and firmness, better sleep architecture, faster recovery, and — in many users — reduced joint and connective tissue discomfort.
When all three are optimized—along with insulin sensitivity, training, and recovery—the results are dramatic and sustainable. But without proper androgen signaling and estrogen control, IGF-1 alone often produces a soft, underpowered physiquerather than dense, strong muscle. ASTB was designed to optimize the entire anabolic environment, not just inflate testosterone numbers. Estrogen is not the enemy—but excess estrogen is anabolic poison.
RE-induced increases in key endogenous steroid and peptide hormone responses are likely to be an integral part of the integrated response to acute exercise and exercise-induced muscle growth. The local production of IGF-1 is controlled primarily by GH and other hormones (e.g., parathyroid and thyroid hormones) (Bikle et al., 2015); suggesting GH's effect on growth may be mediated in part via increased local IGF-1 production and/or action. Future trials are needed to clarify the effects of the oestrogens on muscle biology under different conditions e.g., phase of menstrual cycle, pre or post-menopause, and the response to nutrition (fasting/feeding) and exercise training (Hansen, 2018). For example, low estrogen in the early follicular stage, may negatively affect RE-induced increases in estrogen levels (Hansen et al., 2012), while, in the luteal phase where circulating progesterone is relatively high, may also counteract the sensitizing effects of estrogen on muscle impairing any benefit of acute RE-induced during these phases (Hansen, 2018). That said, increases in testosterone in females have been reported in response to RE in some (Nindl et al., 2001; Copeland et al., 2002), but not all (Marx et al., 2001; Linnamo et al., 2005) studies, albeit with claims of no, or limited, effects of acute testosterone elevations in relation to muscle growth in women (Kraemer et al., 2017). Despite the contrasting hormonal profiles and significantly different acute testosterone responses in these environments, muscle mass and strength gains were comparable, suggesting that the role of testosterone (and other hormones) in exercise induced muscle adaptation is minimal.

Gender: Female

Social links